HER 2 and EGFR: signaling mechanisms and targets for anti-cancer therapies

被引：0
|
作者：
Yosef, Yarden [1 ]
机构：
[1] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
来源：
TUMOR BIOLOGY | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [31] Evolution of anti-HER2 therapies for cancer treatment
    Parakh, Sagun
    Gan, Hui K.
    Parslow, Adam C.
    Burvenich, Ingrid J. G.
    Burgess, Antony W.
    Scott, Andrew M.
    CANCER TREATMENT REVIEWS, 2017, 59 : 1 - 21
  • [32] Advances in Small-Molecule Dual Inhibitors Targeting EGFR and HER2 Receptors as Anti-Cancer Agents
    Kang, Jia-Xiong
    Li, Chao
    Cheng, Yi-Mei
    Huang, Mou-Xin
    Zhao, Guang-Kuan
    Jin, Zhi-Liang
    Qi, Xiao-Wei
    Gu, Jing
    Ouyang, Qin
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [33] Mechanisms of resistance to anti EGFR therapies in colorectal cancers
    Bardelli, Alberto
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [34] Small Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities
    Zubair, Tanzida
    Bandyopadhyay, Debasish
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [35] Cancer immunology - development of novel anti-cancer therapies
    Rothschild, Sacha I.
    Thommen, Daniela S.
    Moersig, Wolfgang
    Mueller, Philipp
    Zippelius, Alfred
    SWISS MEDICAL WEEKLY, 2015, 145
  • [36] Genotype Driven Anti-Cancer Therapies for Colon Cancer
    Mockus, Susan
    Stafford, Grace
    Potter, Christopher
    Ananda, Guruprasad
    Hinerfeld, Douglas
    Tsongalis, Gregory
    MODERN PATHOLOGY, 2015, 28 : 180A - 180A
  • [37] Genotype Driven Anti-Cancer Therapies for Colon Cancer
    Mockus, Susan
    Stafford, Grace
    Potter, Christopher
    Ananda, Guruprasad
    Hinerfeld, Douglas
    Tsongalis, Gregory
    LABORATORY INVESTIGATION, 2015, 95 : 180A - 180A
  • [38] Anti-cancer therapies targeting the tumor stroma
    Valeska Hofmeister
    David Schrama
    Jürgen C. Becker
    Cancer Immunology, Immunotherapy, 2008, 57 : 1 - 17
  • [39] Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells
    Kim, Jinkyoung
    Lee, Jiyun
    Kim, Chungyeul
    Choi, Jinhyuk
    Kim, Aeree
    TUMOR BIOLOGY, 2016, 37 (05) : 5811 - 5819
  • [40] Nuclear assembly as a target for anti-cancer therapies
    Gorjanacz, Matyas
    NUCLEUS, 2014, 5 (01) : 47 - 55
12345